According to our (Global Info Research) latest study, the global Aortic and Peripheral Vascular Interventional Therapy Product market size was valued at US$ 11498 million in 2025 and is forecast to a readjusted size of US$ 18530 million by 2032 with a CAGR of 7.1% during review period.
Aortic and Peripheral Vascular Interventional Therapy Products refer to a range of medical devices and integrated solutions used for the diagnosis and treatment of aortic and peripheral vascular diseases through minimally invasive, image-guided procedures. These products include aortic stent grafts, peripheral vascular stents, balloon catheters, guidewires and catheter systems, thrombectomy devices, and drug-coated devices. They are primarily used to treat conditions such as aortic aneurysms, aortic dissections, peripheral arterial stenosis or occlusions, and venous thrombosis. The core principle involves delivering devices precisely to target lesions via percutaneous vascular access to reconstruct vessels, exclude diseased segments, or restore blood flow. Compared with traditional open surgery, these products offer reduced trauma, faster recovery, and expanding clinical indications, representing a key evolution toward minimally invasive, precise, and integrated cardiovascular therapies.The average gross profit margin of this product is 73%.
The increasing incidence of aortic and peripheral vascular diseases, driven by aging populations and the widespread prevalence of hypertension and atherosclerosis, is supporting steady growth in interventional treatment demand. Clinical practices are shifting from open surgery to minimally invasive interventions, accelerating the adoption of endovascular aortic repair and peripheral interventions. Meanwhile, continuous advancements in stent graft technologies, low-profile delivery systems, and imaging navigation have significantly improved procedural safety and success rates. In addition, ongoing improvements in healthcare systems and rising affordability in emerging markets provide long-term growth momentum. This field is characterized by high technical complexity, with strict requirements for product design, material performance, and clinical validation, leading to long development cycles and substantial investment. Aortic intervention products, in particular, present high entry barriers, with leading multinational companies dominating the high-end segment, while local players face both technological and branding challenges. Policy factors such as centralized procurement and healthcare cost control exert pricing pressure and compress profit margins. Furthermore, complex anatomical structures and high-risk cases increase dependence on physician expertise, introducing uncertainty in clinical adoption. Clinical demand is evolving toward precision and personalization, placing higher requirements on device adaptability, long-term durability, and ease of operation. In aortic disease treatment, there is a growing trend toward early intervention and standardized management, driving demand for high-performance stent grafts. In the peripheral vascular field, greater emphasis is placed on managing long lesions and reducing restenosis. Healthcare services are gradually extending to primary care settings, increasing demand for standardized and user-friendly products. Additionally, rising needs in venous diseases and complex vascular reconstruction are driving further segmentation of product offerings. Upstream materials mainly include metallic materials, polymer materials, and biomedical coating materials, with nitinol, cobalt-chromium alloys, and polytetrafluoroethylene being key foundational materials. These materials directly determine radial strength, flexibility, and long-term stability, while also influencing biocompatibility and safety. Currently, high-end raw materials still partially rely on imports, making supply chain stability and cost control critical concerns. With advancements in material technologies and the acceleration of localization, domestic substitution is increasing, although higher requirements for quality control and manufacturing consistency are emerging.
This report is a detailed and comprehensive analysis for global Aortic and Peripheral Vascular Interventional Therapy Product market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Aortic and Peripheral Vascular Interventional Therapy Product market size and forecasts, in consumption value ($ Million), 2021-2032
Global Aortic and Peripheral Vascular Interventional Therapy Product market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Aortic and Peripheral Vascular Interventional Therapy Product market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Aortic and Peripheral Vascular Interventional Therapy Product market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Aortic and Peripheral Vascular Interventional Therapy Product
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Aortic and Peripheral Vascular Interventional Therapy Product market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, BD, Biotronik, Boston Scientific, Medtronic, Merit Medical, Terumo, Teleflex, Cook Medical, Cordis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Aortic and Peripheral Vascular Interventional Therapy Product market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Stent
Catheter
Guidewire
Sheath
Vena Cava Filter
Other
Market segment by Diseases
Arterial Diseases
Venous Diseases
Market segment by Material
Metallic Devices
Polymer Devices
Market segment by Application
Hospital
Clinic
Other
Market segment by players, this report covers
Abbott
BD
Biotronik
Boston Scientific
Medtronic
Merit Medical
Terumo
Teleflex
Cook Medical
Cordis
Alvimedica
Lepu Medical
Zylox-Tonbridge Medical
Endovastec
ACOTEC
LifeTech Scientific
WEGO
Brosmed
DK MEDTECH
Barty Medical
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Aortic and Peripheral Vascular Interventional Therapy Product product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Aortic and Peripheral Vascular Interventional Therapy Product, with revenue, gross margin, and global market share of Aortic and Peripheral Vascular Interventional Therapy Product from 2021 to 2026.
Chapter 3, the Aortic and Peripheral Vascular Interventional Therapy Product competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Aortic and Peripheral Vascular Interventional Therapy Product market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Aortic and Peripheral Vascular Interventional Therapy Product.
Chapter 13, to describe Aortic and Peripheral Vascular Interventional Therapy Product research findings and conclusion.
Summary:
Get latest Market Research Reports on Aortic and Peripheral Vascular Interventional Therapy Product. Industry analysis & Market Report on Aortic and Peripheral Vascular Interventional Therapy Product is a syndicated market report, published as Global Aortic and Peripheral Vascular Interventional Therapy Product Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Aortic and Peripheral Vascular Interventional Therapy Product market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.